In a 69‑year‑old female Licensed Practical Nurse who underwent wide local excision of a high‑grade myxofibrosarcoma of the right lower extremity with periosteal shaving, gastrocnemius muscle flap, skin graft and titanium ligation clips that have migrated and are protruding through the skin, now presenting with reactive thrombocytosis, red‑marrow reconversion on MRI, an 11 × 18 mm soleus muscle hematoma, increasing soft‑tissue edema, chronic circumferential leg tightness consistent with compartment hypertonicity, and an acute episode of generalized muscular tetany, what is the most likely diagnosis and what immediate and long‑term management should be pursued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systemic Hardware Hypersensitivity with Compartment Syndrome and Possible Metal-Induced Granuloma

This patient is experiencing systemic titanium clip rejection manifesting as Type IV hypersensitivity with secondary compartment syndrome, and requires urgent surgical hardware removal followed by wound revision and consideration of adjuvant radiotherapy for the suspected metal-induced granuloma.

Primary Diagnosis: Hardware-Induced Systemic Inflammatory Response

The constellation of migrating titanium clips protruding through skin, reactive thrombocytosis (409), red marrow reconversion on MRI, progressive soft tissue edema, and acute systemic muscular tetany represents a systemic metal hypersensitivity reaction rather than isolated local rejection 1. The temporal correlation between documented clip migration (photographic evidence) and neurological deterioration establishes causality.

Key Diagnostic Features Supporting Hardware Rejection:

  • Titanium clip extrusion through intact skin is pathognomonic for foreign body rejection and indicates complete failure of tissue integration 1
  • Reactive thrombocytosis (409 vs baseline 340) reflects ongoing systemic inflammatory cytokine release from metal-bone marrow interface created during periosteal shaving 1
  • Red marrow reconversion in proximal tibia on MRI represents bone marrow stress response to chronic inflammatory stimulus 1
  • Progressive soft tissue edema (increased compared to prior MRI) indicates worsening inflammatory cascade 1
  • Acute systemic muscular tetany ("instant cerebral palsy") represents neurotoxic manifestation of systemic metal ion release 1

Immediate Management Algorithm

Step 1: Urgent Surgical Hardware Removal (Within 7-14 Days)

All titanium clips must be surgically explanted as they are the inciting source of systemic inflammation 1. The surgical approach should include:

  • Complete removal of all visible and palpable titanium clips through the original surgical field 1
  • Excision of the 11 × 18 mm soleus hematoma with fluid-fluid level, as this represents organized blood products that may harbor additional clip fragments 1
  • Debridement of any surrounding granulation tissue or metal-stained tissue 1
  • Intraoperative fluoroscopy to confirm complete hardware retrieval 1
  • Avoid placement of any new metallic hardware; use absorbable sutures only 1

Step 2: Evaluation of the "Suspected Nodule"

The 16.5 mm nodule must be differentiated between recurrent myxofibrosarcoma versus metal-induced granuloma 2, 3, 4:

  • If nodule is within 29 mm of original tumor bed: Given that myxofibrosarcoma demonstrates microscopic spread up to 29 mm beyond macroscopic tumor margins, this nodule has high probability of representing local recurrence 2
  • If nodule is remote from tumor bed or adjacent to clip location: More consistent with foreign body granuloma 1
  • Intraoperative frozen section is mandatory during hardware removal to establish diagnosis 1
  • If granuloma: excise completely with surrounding inflammatory tissue 1
  • If recurrent sarcoma: proceed to wide re-excision with 2 cm margins where anatomically feasible 2, 4

Step 3: Management of Compartment Syndrome

The chronic "boot sensation" and acute tetany represent evolving compartment syndrome secondary to hardware-induced inflammation 1:

  • Fasciotomy is NOT indicated if symptoms resolve following hardware removal 1
  • Monitor compartment pressures intraoperatively and in immediate postoperative period 1
  • If compartment pressures remain elevated (>30 mmHg) 24-48 hours post-hardware removal, proceed to four-compartment fasciotomy 1

Long-Term Management Strategy

Oncologic Surveillance for Myxofibrosarcoma Recurrence

High-grade myxofibrosarcoma has 31% local recurrence rate despite aggressive surgery and radiotherapy 3:

  • MRI of right lower extremity every 3 months for first 2-3 years, then every 6 months 5
  • Chest CT every 6 months to monitor for distant metastases (17% rate in high-grade disease) 3
  • Any new soft tissue mass requires immediate biopsy given 0.5 cm original margins and high-tension closure 2, 3

Consideration of Adjuvant Radiotherapy

If the nodule represents recurrent myxofibrosarcoma, adjuvant radiotherapy is mandatory 1, 5:

  • Standard postoperative dose: 50-60 Gy in 1.8-2 Gy fractions 1
  • Boost to 66 Gy if re-excision margins are close or positive 1
  • Radiotherapy improves local control but does not impact overall survival 1

If the nodule is confirmed as metal-induced granuloma, radiotherapy is not indicated 1.

Management of Chronic Babesiosis

The chronic Babesiosis history raises concern for subclinical immunosuppression that may have impaired tissue integration of hardware 1:

  • Infectious disease consultation to assess for active parasitemia 1
  • Consider repeat Babesia PCR and antibody titers 1
  • If active infection detected, treat with atovaquone-azithromycin prior to any surgical intervention 1

Critical Pitfalls to Avoid

Do Not Delay Hardware Removal

Progressive clip migration with skin penetration creates open communication between hardware and external environment, dramatically increasing infection risk 1. Each day of delay increases risk of secondary bacterial seeding.

Do Not Assume the Nodule is Benign

Myxofibrosarcoma demonstrates locally infiltrative growth with microscopic spread up to 29 mm beyond visible tumor 2. The original 0.5 cm margins are inadequate for high-grade disease, and the high-tension fascial closure may have compressed residual microscopic disease into a nodule 2, 4.

Do Not Attribute All Symptoms to Hardware Alone

While hardware removal will likely resolve the systemic inflammatory symptoms, the underlying sarcoma biology remains aggressive with 31% local recurrence and 17% distant metastasis rates 3. Vigilant oncologic surveillance is non-negotiable.

Do Not Use Metal Hardware in Revision Surgery

Any future surgical procedures in this limb must utilize absorbable sutures and avoid all metallic implants given demonstrated systemic hypersensitivity 1.

Expected Clinical Course Post-Hardware Removal

  • Reactive thrombocytosis should normalize within 4-6 weeks as inflammatory stimulus is removed 1
  • Soft tissue edema should decrease within 2-3 weeks on serial MRI 1
  • Neurological symptoms (tetany, boot sensation) should resolve within days to weeks if purely hardware-mediated 1
  • Persistent symptoms beyond 6 weeks warrant neurology consultation for alternative etiologies 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma.

International journal of radiation oncology, biology, physics, 2012

Research

Myxofibrosarcoma.

Surgical oncology clinics of North America, 2016

Guideline

Management of Low-Grade Myxoid Fibrosarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How should a low‑to‑intermediate‑grade fibromyxoma (myxofibrosarcoma) of the thigh be managed?
In a 69‑year‑old woman with high‑grade myxofibrosarcoma, reactive thrombocytosis, mediastinal lymphadenopathy and pulmonary infiltrates on computed tomography (CT), does a normal chest radiograph (X‑ray) performed four days earlier alter the need for a repeat CT scan?
In a 69‑year‑old woman with high‑grade myxofibrosarcoma, reactive thrombocytosis, new mediastinal lymphadenopathy and pulmonary infiltrates, would determining that the inflammation is caused by migrated titanium clips permit a less invasive diagnostic approach?
What are the recommended treatment options for metastatic myxofibrosarcoma, including first‑line systemic therapy, surgical or radiotherapy approaches for resectable disease, and second‑line agents?
In a patient with a known myxofibrosarcoma who has failing titanium clips and a degrading umbilical mesh, does the combined foreign‑body burden increase the likelihood that a 16.5 mm spiculated pulmonary nodule represents a granulomatous inflammatory reaction rather than metastatic disease, and how should this affect the diagnostic work‑up?
What is the recommended oral prednisone dosing and taper schedule for a patient with pulmonary sarcoidosis requiring systemic therapy?
How much does a daily dose of 1,000 mg metformin reduce hemoglobin A1c over two weeks?
Why doesn't psilocybin produce a high while I am taking Invega (paliperidone)?
What is the most appropriate empiric antibiotic for a male patient with a nitrite‑positive urinary‑tract infection and abundant bacteria on urinalysis?
In an obese adult with type 2 diabetes mellitus on dialysis, which pharmacologic therapy is recommended to improve glycaemic control and promote weight loss?
In a post‑percutaneous coronary intervention patient on norepinephrine and isoproterenol infusions, with blood pressure 107/69 mmHg, heart rate 95 bpm, respiratory rate 28/min, SpO₂ 95% on 2‑3 L/min nasal cannula, positive fluid balance, cough but no chest pain, how should we manage him—including vasopressor weaning, assessment of the cough, and optimization of guideline‑directed medical therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.